Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar

Contributed by: GlobeNewswire

Tags

Pharmaceuticals

More Like This

Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances

Avextra Announces the Approval of NEUROBIS by the Italian Medicines Agency: A Phase II Clinical Trial Using a Proprietary Cannabis-based Medicine for the Treatment of the Symptoms of Neurodegenerative Diseases

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal

Tilray Expands Medical Cannabis Portfolio in Germany

Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings

Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations